Aromatase inhibitors and cardiac toxicity: getting to the heart of the matter Sonal GandhiSunil Verma Review 09 January 2007 Pages: 1 - 9
Connexin26 expression is associated with lymphatic vessel invasion and poor prognosis in human breast cancer Yasuto NaoiYasuo MiyoshiShinzaburo Noguchi Preclinical Study 03 January 2007 Pages: 11 - 17
Changes in shoulder muscle size and activity following treatment for breast cancer Delva R. ShamleyRagavan SrinanaganathanElaine Sugden Preclinical Study 13 January 2007 Pages: 19 - 27
Delayed tumor onset and reduced tumor growth progression after immunization with a Her-2/neu multi-peptide vaccine and IL-12 in c-neu transgenic mice Stefan WagnerJoanna JasinskaUrsula Wiedermann Preclinical Study 03 January 2007 Pages: 29 - 38
Insulin receptor is an independent predictor of a favorable outcome in early stage breast cancer Anna Marie MulliganFrances P. O’MalleyPamela J. Goodwin Preclinical Study 13 January 2007 Pages: 39 - 47
Down-regulation of PHLDA1 gene expression is associated with breast cancer progression Maria Aparecida NagaiJosé Humberto T. G. FregnaniFernando A. Soares Preclinical Study 09 January 2007 Pages: 49 - 56
A new polymorphism in the coding region of exon four in HSD17B2 in relation to risk of sporadic and hereditary breast cancer Agneta JanssonJonas CarlssonOlle Stål Preclinical Study 27 January 2007 Pages: 57 - 64
Contrast-enhanced magnetic resonance mammography: does it affect surgical decision-making in patients with breast cancer? Federica PediconiCarlo CatalanoRoberto Passariello Clinical Trial 03 January 2007 Pages: 65 - 74
Reduction in proliferation with six months of letrozole in women on hormone replacement therapy Carol J. FabianBruce F. KimlerBrian K. Petroff Clinical Trial 13 January 2007 Pages: 75 - 84
Possible socioeconomic and ethnic disparities in quality of life in a cohort of breast cancer survivors Deborah J. BowenCatherine M. AlfanoRachel Ballard Barbash Clinical Trial 27 January 2007 Pages: 85 - 95
Fulvestrant in heavily pre-treated patients with advanced breast cancer: results from a single compassionate use programme centre Chiara CataniaGilda AscioneFranco Nolè Clinical Trial 27 January 2007 Pages: 97 - 103
Fulvestrant (‘Faslodex’) in heavily pretreated postmenopausal patients with advanced breast cancer: single centre clinical experience from the compassionate use programme Brigitte MlineritschOskar PsenakRichard Greil Clinical Trial 13 February 2007 Pages: 105 - 112
A decade of breast cancer screening in The Netherlands: trends in the preoperative diagnosis of breast cancer Lucien E. M. DuijmJohanna H. GroenewoudJacques Fracheboud Epidemiology 12 January 2007 Pages: 113 - 119
Two-stage case-control study of common ATM gene variants in relation to breast cancer risk Chuanzhong YeQi DaiWei Zheng Epidemiology 13 March 2007 Pages: 121 - 126
Body mass index and HER-2 overexpression in breast cancer patients over 50 years of age T. Van MieghemK. LeunenP. Neven Epidemiology 09 January 2007 Pages: 127 - 133
Racial differences in breast cancer survival in women under age 60 Malabika SarkerIsmail JatoiHeiko Becher Epidemiology 13 February 2007 Pages: 135 - 141
Predictive factors for late normal tissue complications following radiotherapy for breast cancer Carmen LillaChristine B. AmbrosoneJenny Chang-Claude Epidemiology 13 January 2007 Pages: 143 - 150